Inhalation Asia is a non-commercial conference that aims to provide an opportunity for people who work on pulmonary and intranasal drug delivery in Asia to network and showcase their research, products and services. The event will take place at the Hong Kong Science and Technology Park in Sha Tin.
CrystecPharma are attending CPhI in Frankfurt in November, where CEO, Paul Thorning, will participate on the pane of “The Future of Medicine: What are the therapies of tomorrow?”. Contact us today to schedule a meeting at the event, to learn more about how we could help you to improve product performance and accelerate development timelines.
Crystec are honoured to have been awarded the Making Pharmaceuticals Award for Innovation in Manufacturing. The award was presented for Crystec’s mSAS® (modified Supercritical Anti-Solvent) technology and chosen from shortlisted companies including kg-pharma, iDi Pac, Glatt Protech and SSPC, Bernal Institute.
Crystec’s CEO, Paul Thorning, has contributed to an article by UBM featuring the big issues affecting Pharma for 2019, according to key opinion leaders in the industry. Contributors include representatives from PharmSource, Catalent Pharma Solutions and NIBRT.